tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum

C127H97F3N18Pt4-12 — CID 160643796

IUPACtris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum
SMILESCc1nc(C)c(-c2[c-]cccc2)[n-]1.Cc1nc(C)c(-c2[c-]cccc2)[n-]1.Cc1nc(C)c(-c2[c-]cccc2)[n-]1.Cc1nn(-c2[c-]cccc2)c(C)c1-c1ccc(-c2ccccc2)cc1.FC(F)(F)c1n[n-]c(-c2[c-]cccc2)n1.[Pt].[Pt].[Pt].[Pt].[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1.[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1.[c-]1ccccc1-n1ncc(-c2ccc(-c3ccccc3)cc2)n1
InChIInChI=1S/C23H19N2.2C21H15N2.C20H14N3.3C11H10N2.C9H4F3N3.4Pt/c1-17-23(18(2)25(24-17)22-11-7-4-8-12-22)21-15-13-20(14-16-21)19-9-5-3-6-10-19;2*1-3-7-17(8-4-1)18-11-13-19(14-12-18)20-15-22-23(16-20)21-9-5-2-6-10-21;1-3-7-16(8-4-1)17-11-13-18(14-12-17)20-15-21-23(22-20)19-9-5-2-6-10-19;3*1-8-11(13-9(2)12-8)10-6-4-3-5-7-10;10-9(11,12)8-13-7(14-15-8)6-4-2-1-3-5-6;;;;/h3-11,13-16H,1-2H3;2*1-9,11-16H;1-9,11-15H;3*3-6H,1-2H3;1-4H;;;;/q4*-1;4*-2;;;;
InChIKeyMMYVRFSCGINFGT-UHFFFAOYSA-N
MW2712.60 g/mol
LogP28.32
Rot. Bonds16

About tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum

tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum (PubChem CID 160643796) has the molecular formula C127H97F3N18Pt4-12 and a molecular weight of 2712.60 g/mol. Its IUPAC name is tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum.

Molecular Properties

Compound Nametris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum
PubChem CID160643796
Molecular FormulaC127H97F3N18Pt4-12
Molecular Weight2712.60 g/mol
Exact Mass2710.68
IUPAC Nametris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum
SMILESCc1nc(C)c(-c2[c-]cccc2)[n-]1.Cc1nc(C)c(-c2[c-]cccc2)[n-]1.Cc1nc(C)c(-c2[c-]cccc2)[n-]1.Cc1nn(-c2[c-]cccc2)c(C)c1-c1ccc(-c2ccccc2)cc1.FC(F)(F)c1n[n-]c(-c2[c-]cccc2)n1.[Pt].[Pt].[Pt].[Pt].[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1.[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1.[c-]1ccccc1-n1ncc(-c2ccc(-c3ccccc3)cc2)n1
InChIInChI=1S/C23H19N2.2C21H15N2.C20H14N3.3C11H10N2.C9H4F3N3.4Pt/c1-17-23(18(2)25(24-17)22-11-7-4-8-12-22)21-15-13-20(14-16-21)19-9-5-3-6-10-19;2*1-3-7-17(8-4-1)18-11-13-19(14-12-18)20-15-22-23(16-20)21-9-5-2-6-10-21;1-3-7-16(8-4-1)17-11-13-18(14-12-17)20-15-21-23(22-20)19-9-5-2-6-10-19;3*1-8-11(13-9(2)12-8)10-6-4-3-5-7-10;10-9(11,12)8-13-7(14-15-8)6-4-2-1-3-5-6;;;;/h3-11,13-16H,1-2H3;2*1-9,11-16H;1-9,11-15H;3*3-6H,1-2H3;1-4H;;;;/q4*-1;4*-2;;;;
InChIKeyMMYVRFSCGINFGT-UHFFFAOYSA-N
XLogP28.32
TPSA205.02 Ų
H-Bond Donors
H-Bond Acceptors14
Rotatable Bonds16
Heavy Atoms152
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002712.60
LogP ≤ 528.32
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-(3-Tert-butyl-5-pyrazol-1-ylbenzene-6-id-1-yl)-5-methylimidazol-3-ide;4-(3-tert-butyl-5-pyrazol-1-ylbenzene-6-id-1-yl)-5-(trifluoromethyl)imidazol-3-ide;[2-diphenylphosphorylethyl(phenyl)phosphoryl]benzene;bis(platinum(2+))
CID 57724184
4-(3-Tert-butyl-5-pyrazol-1-ylbenzene-6-id-1-yl)-5-methylimidazol-3-ide;4-(3-tert-butyl-5-pyrazol-1-ylbenzene-6-id-1-yl)-5-(trifluoromethyl)imidazol-3-ide;2-diphenylphosphaniumylethyl(diphenyl)phosphanium;bis(platinum(2+))
CID 57724209
Bis(4-(3-tert-butyl-5-pyrazol-1-ylbenzene-6-id-1-yl)-5-(trifluoromethyl)imidazol-3-ide);2-diphenylphosphaniumylethyl(diphenyl)phosphanium;bis(platinum(2+))
CID 58725729
3,5-Dimethyl-1-phenylpyrazole;3,5-dimethyl-2-phenylpyrazol-2-ium-1-ide;iridium;2-[5-[4-(trifluoromethyl)phenyl]-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine
CID 58855106
Iridium;1-phenylpyrazole;2-phenylpyrazol-2-ium-1-ide;2-[5-[4-(trifluoromethyl)phenyl]-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine
CID 58855107
Bis(1-benzyl-3-(2-ethoxy-4-fluorobenzene-6-id-1-yl)pyrazole);iridium(3+);5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide
CID 58898662
Bis(1-benzyl-3-(2-ethoxy-4-fluorobenzene-6-id-1-yl)pyrazole);5-(1-benzylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;iridium(3+)
CID 58898682
Bis(3-(4-fluorobenzene-6-id-1-yl)-1-methyl-5-(trifluoromethyl)pyrazole);iridium(3+);5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide
CID 58898684
Bis(1-benzyl-3-(2-ethoxy-4-fluorobenzene-6-id-1-yl)pyrazole);iridium(3+);3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene
CID 58898704
4-[4-[1,1,1,3,3,3-Hexafluoro-2-(4-pyrazolo[1,5-a]benzimidazol-4-ylphenyl)propan-2-yl]phenyl]pyrazolo[1,5-a]benzimidazole
CID 59500326
1,2-Bis[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-1,2-bis[8-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]hydrazine
CID 87577660
N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine
CID 90702538

Frequently Asked Questions

What is the IUPAC name of tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum?
The IUPAC name of tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum (CID 160643796) is tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum.
What is the SMILES notation for tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum?
The canonical SMILES for tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum is Cc1nc(C)c(-c2[c-]cccc2)[n-]1.Cc1nc(C)c(-c2[c-]cccc2)[n-]1.Cc1nc(C)c(-c2[c-]cccc2)[n-]1.Cc1nn(-c2[c-]cccc2)c(C)c1-c1ccc(-c2ccccc2)cc1.FC(F)(F)c1n[n-]c(-c2[c-]cccc2)n1.[Pt].[Pt].[Pt].[Pt].[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1.[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1.[c-]1ccccc1-n1ncc(-c2ccc(-c3ccccc3)cc2)n1.
What is the InChIKey of tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum?
The InChIKey is MMYVRFSCGINFGT-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H19N2.2C21H15N2.C20H14N3.3C11H10N2.C9H4F3N3.4Pt/c1-17-23(18(2)25(24-17)22-11-7-4-8-12-22)21-15-13-20(14-16-21)19-9-5-3-6-10-19;2*1-3-7-17(8-4-1)18-11-13-19(14-12-18)20-15-22-23(16-20)21-9-5-2-6-10-21;1-3-7-16(8-4-1)17-11-13-18(14-12-17)20-15-21-23(22-20)19-9-5-2-6-10-19;3*1-8-11(13-9(2)12-8)10-6-4-3-5-7-10;10-9(11,12)8-13-7(14-15-8)6-4-2-1-3-5-6;;;;/h3-11,13-16H,1-2H3;2*1-9,11-16H;1-9,11-15H;3*3-6H,1-2H3;1-4H;;;;/q4*-1;4*-2;;;;.
What are the key properties of tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum?
tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum has a molecular weight of 2712.60 g/mol, XLogP of 28.32, 16 rotatable bonds, 0 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for tris(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);2-phenyl-4-(4-phenylphenyl)triazole;3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum is sourced from PubChem (CID 160643796), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).